{"product_id":"lgals8-antibody-sc-f2772","title":"Galectin 8\/Gal-8 Antibody","description":"\u003ch2\u003eAbout the Target\u003c\/h2\u003e\u003cp\u003eLGALS8 is a target of interest in many antibody-based workflows. Galectin 8\/Gal-8 is a tandem-repeat-type β-galactoside-binding lectin widely expressed in human tissues and involved in diverse physiological and pathological processes. It contains two distinct carbohydrate recognition domains (N-CRD and C-CRD) connected by a linker peptide of variable length (33 aa in Gal-8S, 75 aa in Gal-8L), with the N-CRD uniquely showing high affinity for α2-3-sialylated or 3′-sulfated β-galactosides, and the C-CRD preferentially binding branched N-glycans. Depending on the literature source, LGALS8 may also be discussed as Galectin 8\/Gal-8 and Galectin-8.\u003c\/p\u003e\u003cp\u003eReported cellular context includes cytoplasm and cytoplasmic vesicle, which can matter when signal is compared across treatments or changing cell states. Following LGALS8 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.\u003c\/p\u003e\u003ch2\u003eResearch Context\u003c\/h2\u003e\u003cp\u003eLGALS8 is commonly interpreted in the context of cancer and immunology research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cytoplasm and cytoplasmic vesicle, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.\u003c\/p\u003e\u003cp\u003eConsider these angles when interpreting target-level changes:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eapparent redistribution between cytoplasm and cytoplasmic vesicle across matched conditions\u003c\/li\u003e\n\u003cli\u003echanges associated with proliferative state, oncogenic signaling, or treatment response\u003c\/li\u003e\n\u003cli\u003econtext differences tied to immune-cell state, activation, or lineage composition\u003c\/li\u003e\n\u003cli\u003eco-patterning with orthogonal markers and control conditions that clarify pathway state\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eVariant Considerations\u003c\/h2\u003e\u003cp\u003eIf your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for LGALS8. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.\u003c\/p\u003e\u003cp\u003eStandardize sampling time, control choice, and downstream analysis thresholds so apparent differences in LGALS8 reflect biology rather than handling. When interpreting LGALS8, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.\u003c\/p\u003e\u003cp\u003eFor multi-run studies, a shared reference condition can keep LGALS8 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.\u003c\/p\u003e","brand":"Selleck Chemicals","offers":[{"title":"20 µl","offer_id":57577971253593,"sku":"F2772-20UL","price":149.0,"currency_code":"EUR","in_stock":true},{"title":"100 µl","offer_id":57577971286361,"sku":"F2772-100UL","price":369.0,"currency_code":"EUR","in_stock":true},{"title":"2 × 100 µl","offer_id":57577971319129,"sku":"F2772-2X100UL","price":549.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0923\/1011\/0553\/files\/F2772-IF.png?v=1773600681","url":"https:\/\/absource-diagnostics.myshopify.com\/products\/lgals8-antibody-sc-f2772","provider":"Absource Diagnostics","version":"1.0","type":"link"}